Advanced Cell Models – Products

Are you looking for a more physiologically relevant way to study cell behavior? Cultrex BME matrices allow you to create a realistic microenvironment for your cells, enabling you to create complex multicellular structures that more closely resemble the structure and function of tissues in the body.

The CellXpress.ai™ Automated Cell Culture System is an AI-driven cell culture innovation hub that automates the entire cell culture process to improve 2D and 3D biological workflows and make assays more reliable and reproducible.

This app note highlights a method for generating highly standardized, assay- ready PDOs and demonstrates their utility in high-throughput applications.

CellCelector is a fully automated cell imaging and picking system developed for the screening, detection, selection and isolation of single cells, clusters, spheroids and organoids, as well as single cell clones and adherent colonies.

InSphero announced that the company is making their 3D in vitro products available to researchers in the European Union market more easily by signing a distribution agreement with Darwin Microfluidics.

A new partnership to provide customers with direct access to highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays. These will alleviate the need for stringent in-house quality control testing to maximize assay success.

AMSBIO has sponsored two aspiring life scientists to attend and present posters at the recent ISSCR 2023 conference in Boston, USA.

Qkine is delighted to announce its collaboration with Sartorius to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.

Thermo Fisher Scientific has announced the launch of the first commercially available culture medium specifically developed for the expansion of patient-derived cancer organoids, from multiple cancer indications.

AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials.